Tag: Bayer

BASF to Buy Bayer’s Seed Assets for Billions

BASF to Buy Bayer’s Seed Assets for Billions

October 21, 2017 |

In New Jersey, BASF agreed to buy almost all of Bayer’s seed assets including LibertyLink seeds and chemistry for $7 billion, assuming the Bayer acquisition of Monsanto goes through. If all goes as planned, BASF will gain 1,800 Bayer employees, 700 of them in North America and 81 Bayer sites. This is BASF’s first time […]

Read More

Psst! The latest bioeconomy flashes from Bayer, Gingko, BioAmber, Joule, TerraVia, Corbion, Phytelligence, DNA Script

Psst! The latest bioeconomy flashes from Bayer, Gingko, BioAmber, Joule, TerraVia, Corbion, Phytelligence, DNA Script

September 14, 2017 |

While we’ve been busy fleeing Hurricane Irma, it’s been a busy week for the techies running the Digest’s Very Large Gossip Array —  the airwaves have been crackling as some familiar faces re-surface. Let’s review. Bayer, Ginkgo’s $100 Million  Baby News just arrived from Germany that Bayer and Ginkgo Bioworks will create a new company […]

Read More

Hook-Up of the Year: The Digest’s 2016 Multi-Slide Guide to Bayer & Monsanto

Hook-Up of the Year: The Digest’s 2016 Multi-Slide Guide to Bayer & Monsanto

September 20, 2016 |

Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Bayer and Monsanto put together this deck on the […]

Read More

Bayer-Monsanto Hook Up: Good News or Bad Tidings for the Advanced Bioeconomy?

Bayer-Monsanto Hook Up: Good News or Bad Tidings for the Advanced Bioeconomy?

September 20, 2016 |

Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 per share all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Reactions to the deal fall into three […]

Read More

Strategic Intent: The Digest 2016 Multi-Slide Guide to Bayer, Bunge and Monsanto

Strategic Intent: The Digest 2016 Multi-Slide Guide to Bayer, Bunge and Monsanto

August 24, 2016 |

This season, we are conducting Strategic Intent, our 19 webinar series on major companies and their partnerships, progress and plans in the Advanced Bioeconomy. In this edition, we explored Bayer, Bunge and Monsanto in the interactive webinar format. Here are the slides from our Digest presentation, focusing on the innovations, M&A activity, target molecules and more for […]

Read More

Ceres licenses genome visualization software to Bayer CropScience

Ceres licenses genome visualization software to Bayer CropScience

July 9, 2014 |

In California, Ceres announced that the company has licensed its Persephone genome visualization application to Bayer CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance. Originally developed for in-house use by Ceres, Persephone allows researchers to rapidly zoom in and […]

Read More

Bayer invests $12M in Evogene, signs five-year R&D deal

Bayer invests $12M in Evogene, signs five-year R&D deal

[ 0 ] December 14, 2010 |

In Germany, Bayer CropScience AG and Evogene have entered into a five-year collaboration to accelerate the development and introduction of improved wheat varieties. Improvements will be pursued for wheat yield, drought tolerance, fertilizer use efficiency and certain other wheat traits utilizing a combination of advanced breeding and state of the art genetic modification methods. Bayer […]

Read More